��������

Chad Green is an accomplished professional in the biotechnology field with extensive experience in technical operations and quality management. Currently serving as Head of Technical Operations and Quality at Outpace Bio since February 2025, Chad previously held the role of Senior Vice President of Technical Operations at Innervace, specializing in regenerative therapies for conditions such as Parkinson's disease. Chad also contributed as Senior Vice President of Technical Operations at Turnstone Biologics, overseeing process development and regulatory responsibilities. Prior positions include Senior Principal at Dark Horse Consulting Group, Senior Director of Technical Operations at Fate Therapeutics, and various roles at ViaCyte focused on device engineering and manufacturing. Chad's early career involved postdoctoral research at both the University of California at San Diego and the University of California at Davis, alongside foundational education culminating in a Ph.D. in Biomedical Engineering from the University of California, Davis.